September 2025 witnessed a whopping surge in North American import price of progesterone due to persistent supply chain disruptions, unstable raw material prices, and increasing global demand. Supply chain issues, based on past geopolitical tensions and trade barriers, have deterred sourcing key raw materials required for manufacturing progesterone. This has pushed manufacturers to shell out a premium for inputs, raising costs for consumers and healthcare providers. Volatility in material prices because of extreme weather patterns and shifts in regulation has also stretched production capacities equally. Furthermore, increasing global demand for hormonal therapy, fueled by increased knowledge of fertility health concerns, is building supply chain pressures. Inflation, combined with high freight costs and shortages of labor, also fuels the tensions. Experts warn that unless phenomenal gains in supply chain reliability and material pricing are realized, progesterone import prices will be sustained at elevated levels, fueled by an unstable economic climate and geopolitical tensions.
